Optimum Sleep is Important for Reducing the Risk of Cardiovascular Mortality & Morbidity


Sleep disorder
Cardiovascular risk

How to Cite

Chakravorty, T. (2021). Optimum Sleep is Important for Reducing the Risk of Cardiovascular Mortality & Morbidity . The Physician, 7(1), 1-6. https://doi.org/10.38192/


Cardiovascular disease (CVD) is the leading cause of death worldwide. Humans spend up to a third of their life asleep, yet sleep problems are common in society [1]. Sleep disorders, such as insomnia and obstructive sleep apnoea, not only affect optimal functioning and productivity but have long term impacts on health. Over the last two decades, emerging research has linked sleep duration, quality and sleep disorders with CVD, metabolic syndrome and obesity. This essay will explore the role of sleep in maintaining a healthy heart, and how strategies to improve sleep can reduce CVD risk.



Institute of Medicine (US) Committee on Sleep Medicine and Research. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. Washington (DC): : National Academies Press (US) 2006. http://www.ncbi.nlm.nih.gov/books/NBK19960/ (accessed 12 Jun 2021).

Cappuccio FP, D’Elia L, Strazzullo P, et al. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010;33:585–92. doi:10.1093/sleep/33.5.585

Watson NF, Badr MS, Belenky G, et al. Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep 2015;38:843–4. doi:10.5665/sleep.4716

Paruthi S, Brooks LJ, D’Ambrosio C, et al. Consensus Statement of the American Academy of Sleep Medicine on the Recommended Amount of Sleep for Healthy Children: Methodology and Discussion. J Clin Sleep Med 2016;12:1549–61. doi:10.5664/jcsm.6288

Grandner MA. Chapter 9 - Obstacles to overcome when improving sleep health at a societal level. In: Grandner MA, ed. Sleep and Health. Academic Press 2019. 107–15. doi:10.1016/B978-0-12-815373-4.00009-5

Knutson KL. Does inadequate sleep play a role in vulnerability to obesity? Am J Hum Biol 2012;24:361–71. doi:10.1002/ajhb.22219

Fernandez‐Mendoza J, He F, Vgontzas AN, et al. Interplay of Objective Sleep Duration and Cardiovascular and Cerebrovascular Diseases on Cause‐Specific Mortality. Journal of the American Heart Association 2019;8:e013043. doi:10.1161/JAHA.119.013043

Hoevenaar-Blom MP, Spijkerman AMW, Kromhout D, et al. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study. Sleep 2011;34:1487–92. doi:10.5665/sleep.1382

McFarlane SI. Shift work and sleep: medical implications and management. SMDIJ 2017;1. doi:10.15406/smdij.2017.01.00008

Ball LJ, Palesh O, Kriegsfeld LJ. The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis. Endocr Rev 2016;37:450–66. doi:10.1210/er.2015-1133

Grandner MA, Patel NP, Perlis ML, et al. Obesity, diabetes, and exercise associated with sleep-related complaints in the American population. Z Gesundh Wiss 2011;19:463–74. doi:10.1007/s10389-011-0398-2

Spiegel K, Tasali E, Leproult R, et al. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol 2009;5:253–61. doi:10.1038/nrendo.2009.23

Huang Y, Cai X, Mai W, et al. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ 2016;355:i5953. doi:10.1136/bmj.i5953

Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435–9. doi:10.1016/S0140-6736(99)01376-8

Tasali E, Leproult R, Spiegel K. Reduced sleep duration or quality: relationships with insulin resistance and type 2 diabetes. Prog Cardiovasc Dis 2009;51:381–91. doi:10.1016/j.pcad.2008.10.002

Insomnia and Risk of Cardiovascular Disease - CHEST. https://journal.chestnet.org/article/S0012-3692(17)30134-4/fulltext (accessed 12 Jun 2021).

Phillips Barbara, Mannino David M. Do Insomnia Complaints Cause Hypertension or Cardiovascular Disease? Journal of Clinical Sleep Medicine 2007;03:489–94. doi:10.5664/jcsm.26913

Routledge FS, Dunbar SB, Higgins M, et al. Insomnia Symptoms Are Associated With Abnormal Endothelial Function. Journal of Cardiovascular Nursing 2017;32:78–85. doi:10.1097/JCN.0000000000000295

Hall MH, Brindle RC, Buysse DJ. Sleep and cardiovascular disease: Emerging opportunities for psychology. Am Psychol 2018;73:994–1006. doi:10.1037/amp0000362

Sleep Apnea and Cardiovascular Disease | Circulation. https://www.ahajournals.org/doi/10.1161/circulationaha.107.189420 (accessed 12 Jun 2021).

Broström A, Sunnergren O, Årestedt K, et al. Factors associated with undiagnosed obstructive sleep apnoea in hypertensive primary care patients. Scand J Prim Health Care 2012;30:107–13. doi:10.3109/02813432.2012.675563

Finkel KJ, Searleman AC, Tymkew H, et al. Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center. Sleep Medicine 2009;10:753–8. doi:10.1016/j.sleep.2008.08.007

Fu Y, Xia Y, Yi H, et al. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment. Sleep Breath 2017;21:181–9. doi:10.1007/s11325-016-1393-1

Obstructive sleep apnoea and its cardiovascular consequences - The Lancet. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61622-0/fulltext (accessed 12 Jun 2021).

Dolezal BA, Neufeld EV, Boland DM, et al. Interrelationship between Sleep and Exercise: A Systematic Review. Adv Prev Med 2017;2017:1364387. doi:10.1155/2017/1364387

Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297–307. doi:10.1016/s1389-9457(00)00065-4

Lip GYH, Barnett AH, Bradbury A, et al. Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management. J Hum Hypertens 2007;21:183–211. doi:10.1038/sj.jhh.1002126

Tordjman S, Chokron S, Delorme R, et al. Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr Neuropharmacol 2017;15:434–43. doi:10.2174/1570159X14666161228122115

Grossman E, Laudon M, Yalcin R, et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med 2006;119:898–902. doi:10.1016/j.amjmed.2006.02.002

Gottlieb DJ, Punjabi NM, Mehra R, et al. CPAP versus Oxygen in Obstructive Sleep Apnea. N Engl J Med 2014;370:2276–85. doi:10.1056/NEJMoa1306766

Fava C, Dorigoni S, Dalle Vedove F, et al. Effect of CPAP on Blood Pressure in Patients With OSA/Hypopnea. Chest 2014;145:762–71. doi:10.1378/chest.13-1115

McNicholas WT. Screening for sleep-disordered breathing: the continuing search for a reliable predictive questionnaire. The Lancet Respiratory Medicine 2016;4:683–5. doi:10.1016/S2213-2600(16)30119-9

Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin Questionnaire To Identify Patients at Risk for the Sleep Apnea Syndrome. Ann Intern Med 1999;131:485–91. doi:10.7326/0003-4819-131-7-199910050-00002

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2021 Array